Genomics, Epigenomics and Personalized Medicine: A Bright Future for Drug Development?

摘要

The sequencing of the human genome marked the beginning of two new fields: personalized genomics and epigenomics. Some companies have already launched personalized genetic tests and whole genome sequencing to predict diseases. Epigenomics has also emerged in the post-genomic era with the objective of cataloguing all modifications in the DNA that have the potential to change the expression of genes. Epigenetics refers to the study of such changes and some drugs have already been launched based in epigenetic mechanisms. This is just the beginning for two fields that are in their infancy and it is clear that new medicines that could revolutionize personalized therapies are on the way.